Skip to main content
ATEX
NASDAQ Technology

Officer Ryan Gerbrandt Files Intent to Sell Over $1 Million in Shares Following Option Exercise

Analysis by Wiseek AI
Sentiment info
Negative
Importance info
7
Price
$40.36
Mkt Cap
$756.059M
52W Low
$17.58
52W High
$43.445
Market data snapshot near publication time

Summary

Anterix Inc. officer Ryan L. Gerbrandt filed a Form 144 to sell 26,889 shares worth $1.08 million, acquired through stock option exercise, continuing a pattern of recent sales totaling $1.81 million.


Key Events

  • Officer Files Intent to Sell Shares

    Ryan L. Gerbrandt, an officer of Anterix Inc., has filed a Form 144 indicating an intent to sell 26,889 shares of common stock.

  • Proposed Sale Value Exceeds $1 Million

    The approximate market value of the shares intended for sale is $1,075,733.20, based on the current stock price.

  • Shares Acquired via Option Exercise

    The shares to be sold were acquired through a stock option exercise on the same day as the proposed sale, indicating a monetization event.

  • Continuation of Recent Sales Pattern

    This filing follows a pattern of sales by Mr. Gerbrandt, who has sold an additional 51,113 shares for gross proceeds of $1,813,184.61 over the past three months.


Analysis

Anterix Inc. officer Ryan L. Gerbrandt has filed a Form 144 indicating an intent to sell 26,889 shares of common stock, valued at approximately $1.08 million. This proposed sale follows the exercise of stock options, a common practice for executives to monetize compensation. This transaction represents a continuation of a pattern, as Gerbrandt has sold an additional 51,113 shares totaling $1.81 million in gross proceeds over the past three months. While sales related to option exercises are often for tax or liquidity purposes, a consistent pattern of officer sales can be viewed negatively by investors, suggesting a lack of conviction or a desire to reduce exposure.

At the time of this filing, ATEX was trading at $40.36 on NASDAQ in the Technology sector, with a market capitalization of approximately $756.1M. The 52-week trading range was $17.58 to $43.45. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

ATEX - Latest Insights

ATEX
Jun 10, 2026, 5:00 PM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $65.00
Real-time Price: $82.81 info
Change: +$17.81 (+27%) info
Market Cap: $1.545B info
ATEX
Jun 10, 2026, 4:45 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $67.77
Real-time Price: $82.81 info
Change: +$15.04 (+22%) info
Market Cap: $1.545B info
ATEX
May 18, 2026, 7:30 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $56.80
Real-time Price: $82.81 info
Change: +$26.01 (+46%) info
Market Cap: $1.545B info
ATEX
Apr 21, 2026, 9:16 AM EDT
Filing Type: 8-K/A
Importance Score:
8
Price at Filing: $42.60
Real-time Price: $82.81 info
Change: +$40.21 (+94%) info
Market Cap: $1.545B info
ATEX
Apr 17, 2026, 4:09 PM EDT
Filing Type: 144
Importance Score:
8
Price at Filing: $42.19
Real-time Price: $82.81 info
Change: +$40.62 (+96%) info
Market Cap: $1.545B info
ATEX
Apr 16, 2026, 4:44 PM EDT
Filing Type: 144
Importance Score:
7
Price at Filing: $40.36
Real-time Price: $82.81 info
Change: +$42.45 (+105%) info
Market Cap: $1.545B info
ATEX
Apr 06, 2026, 7:31 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $38.86
Real-time Price: $82.81 info
Change: +$43.95 (+113%) info
Market Cap: $1.545B info
ATEX
Apr 01, 2026, 7:30 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $38.19
Real-time Price: $82.81 info
Change: +$44.62 (+117%) info
Market Cap: $1.545B info
ATEX
Mar 02, 2026, 5:39 PM EST
Filing Type: 144
Importance Score:
8
Price at Filing: $36.03
Real-time Price: $82.81 info
Change: +$46.78 (+130%) info
Market Cap: $1.545B info
ATEX
Feb 11, 2026, 4:46 PM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $29.70
Real-time Price: $82.81 info
Change: +$53.11 (+179%) info
Market Cap: $1.545B info